BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/16/2024 8:03:14 AM | Browse: 95 | Download: 191
 |
Received |
|
2024-02-29 00:23 |
|
Peer-Review Started |
|
2024-02-29 00:23 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-04-29 20:45 |
|
Revised |
|
2024-06-03 21:56 |
|
Second Decision |
|
2024-07-10 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-07-10 06:17 |
|
Articles in Press |
|
2024-07-10 06:17 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-07-22 23:54 |
|
Typeset the Manuscript |
|
2024-07-29 09:13 |
|
Publish the Manuscript Online |
|
2024-08-16 08:03 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Opinion Review |
| Article Title |
Personalized medicine: Clinical oncology on molecular view of treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rafick Costa Dos Santos Da Silva, Nathalia de Andrade Simon, André Alves Dos Santos, Gabriel De Melo Olegário, Jayne Ferreira Da Silva, Naide Oliveira Sousa, Manuel Alvarez Troncoso Corbacho and Fabrício Freire de Melo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fabrício Freire de Melo, PhD, Professor, Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Rua Hormínio Barros, 58, Candeias, Vitória da Conquista 45029-094, Bahia, Brazil. freiremeloufba@gmail.com |
| Key Words |
Oncology; Neoplasia; Molecular biology; Personalized medicine; Molecular Markers; Cancer |
| Core Tip |
This review emphasizes the importance of precision medicine in cancer treatment, highlighting the role of molecular biology in identifying specific genetic markers for more accurate prognosis and targeted therapies. We discuss the main biomarkers, such as alpha-fetoprotein and programmed death-1, and the revolutionary impact of bioinformatics in the diagnosis of neoplasms. Techniques such as liquid biopsy and immunohistochemistry gain prominence for early detection as a directional tool for therapies. The review also addresses challenges, including costs and tumor heterogeneity, advocating collaborative efforts to ensure these advances are accessible to all. |
| Publish Date |
2024-08-16 08:03 |
| Citation |
<p>Da Silva RCDS, Simon NA, Dos Santos AA, Olegário GDM, Da Silva JF, Sousa NO, Corbacho MAT, de Melo FF. Personalized medicine: Clinical oncology on molecular view of treatment. <i>World J Clin Oncol</i> 2024; 15(8): 992-1001</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i8/992.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i8.992 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
